Paper39197864
Migraine is the most disabling neurological disease among children and adolescents, and second after stroke among adults: A call to action.
Peres MFP and 9 others. Cephalalgia, 2024. Cited by 59 papers, by iCite.
Cite this record
ConductScience Library. Migraine is the most disabling neurological disease among children and adolescents, and second after stroke among adults: A call to action. Papers, record 39197864. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39197864
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Migraine is the most disabling neurological disease among children and adolescents, and second after stroke among adults: A call to action.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Migraine Disorders | Major topic |
| Stroke | Major topic |
| Adolescent | |
| Adult | |
| Child | |
| Humans | |
| Global Burden of Disease |
Source PubMed
Cited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42931331 | Patient-Reported Adherence, Knowledge and Perceived Outcomes After Specialist Nursing Education in a Multidisciplinary Headache Unit: A Cross-Sectional Observational Study. | Nurs Rep | 2026 | https://conductscience.org/library/papers/42931331 | PubMed |
| 42920904 | Migraine burden inequities and 2050 projections in Africa based on global burden of disease 2023. | iScience | 2026 | https://conductscience.org/library/papers/42920904 | PubMed |
| 42866175 | Fremanezumab for episodic migraine in children and adolescents: the evolving landscape of CGRP-targeted therapies. | Transl Pediatr | 2026 | https://conductscience.org/library/papers/42866175 | PubMed |
| 42769685 | Metaverse-Related and Immersive Digital Technologies in Neurorehabilitation: A Scoping Review. | Arch Rehabil Res Clin Transl | 2026 | https://conductscience.org/library/papers/42769685 | PubMed |
| 42761667 | Analysis of Sleep Quality and Its Associated Factors in Adolescents with Migraine. | J Pain Res | 2026 | https://conductscience.org/library/papers/42761667 | PubMed |
| 42743099 | Exploring Proximal and Distal Ultrasound-Guided Greater Occipital Nerve Block Approaches in Migraine: A Systematic Review and Meta-Analysis. | Pain Pract | 2026 | https://conductscience.org/library/papers/42743099 | PubMed |
| 42726340 | Meaningful Measurable Quality Outcomes in Headache Management. | Curr Pain Headache Rep | 2026 | https://conductscience.org/library/papers/42726340 | PubMed |
| 42634802 | Changes in P2X4 receptor expression following AbobotulinumtoxinA treatment in patients with chronic migraine: A case series study. | Curr J Neurol | 2025 | https://conductscience.org/library/papers/42634802 | PubMed |
| 42572641 | Evaluation of Ocular Higher-Order Aberrations in Patients with Migraine: A Comparative Study. | Rom J Ophthalmol | 2026 | https://conductscience.org/library/papers/42572641 | PubMed |
| 42465667 | Adapting to life with chronic migraine: a qualitative study of lived experiences among multi-ethnic Asian patients. | Front Pain Res (Lausanne) | 2026 | https://conductscience.org/library/papers/42465667 | PubMed |
| 42356280 | Integrating Nutrition and Physical Activity into the EXEMIG/01 Interdisciplinary Model for Chronic and High-Frequency Migraine. | Nutrients | 2026 | https://conductscience.org/library/papers/42356280 | PubMed |
| 42348808 | Clinical Differentiation of Self-Limited Epilepsy With Autonomic Seizures (Panayiotopoulos Syndrome) and Childhood Migraine. | Neurol Clin Pract | 2026 | https://conductscience.org/library/papers/42348808 | PubMed |
| 42256516 | The Social Life of Migraine: A Meta-Ethnography of Lived Experience in Adults With Migraine. | Health Serv Insights | 2026 | https://conductscience.org/library/papers/42256516 | PubMed |
| 42185562 | Quality by design based development and optimization of a thermoreversible in situ intranasal gel of zavegepant for nose to brain delivery in migraine therapy. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42185562 | PubMed |
| 42158933 | What's Needed for a Migraine Cost-Of-Illness Study in Aotearoa New Zealand: Review of Data Sources and Gaps. | J R Soc N Z | 2026 | https://conductscience.org/library/papers/42158933 | PubMed |
| 42118419 | Addressing the Treatment Gap for Pediatric Headache in Underserved Regions. | Curr Pain Headache Rep | 2026 | https://conductscience.org/library/papers/42118419 | PubMed |
| 42067810 | Real-world effectiveness of onabotulinumtoxinA as first-line treatment in chronic migraine and sequential transition to anti-CGRP monoclonal antibodies: a retrospective multicenter study. | BMC Neurol | 2026 | https://conductscience.org/library/papers/42067810 | PubMed |
| 42057934 | A study on cortical habituation based on event-related potential P50 and CNV. | Front Neurol | 2026 | https://conductscience.org/library/papers/42057934 | PubMed |
| 41996064 | Long-Term Reductions in Headache Frequency, Severity, and Disability with Eptinezumab in Adults with Chronic Migraine: Results from the PREVAIL Trial. | Pain Ther | 2026 | https://conductscience.org/library/papers/41996064 | PubMed |
| 41987076 | Genome-wide association analysis of treatment response to onabotulinumtoxinA in Han Chinese patients with chronic migraine: a pilot study. | BMC Neurol | 2026 | https://conductscience.org/library/papers/41987076 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39197864
GET https://conductscience.org/api/papers/v1/39197864/cited_by?page=2